How can early coronary artery bypass graft failure be identified and how can graft function be optimized?

Identifying and Optimizing Early Coronary Artery Bypass Graft Function

Identification of Early Graft Failure

Intraoperative transit time flow measurement (TTFM) is the most practical method to identify early graft failure, with specific cutoff values predicting occlusion: mean graft flow <26.5 ml/min for arterial grafts and <36.5 ml/min for venous grafts. 1

Intraoperative Assessment Methods

Transit Time Flow Measurement (TTFM) is the most widely implemented technique for real-time graft assessment during surgery 2:

• Arterial graft failure indicators:

  • Mean flow ≤15-26.5 ml/min 1, 3
  • Pulsatility index (PI) ≥2.3-5.1 1, 4, 3
  • Backward flow ≥4.1% 3
  • Systolic dominant flow pattern (left coronary territory only) 3

• Venous graft failure indicators:

  • Mean flow ≤36.5 ml/min 1
  • Pulsatility index >2.3 4
  • Backward flow ≥4.6% 3

• Right coronary artery grafts have different thresholds: mean flow ≤20 ml/min and PI ≥4.7 3

Coronary resistance measurement during cardioplegic arrest provides additional predictive value: resistances >2.0 mmHg/mL/min show 80% sensitivity and 100% specificity for predicting graft failure 5. This overcomes TTFM's limitation of false negatives (poor grafts with low PI) 2.

Alternative Intraoperative Techniques

While TTFM is most practical, other methods exist 2:

• Intraoperative fluorescence imaging (IFI) evaluates graft anatomy and is more sensitive than TTFM but has greater inter-observer variability 2
• Coronary angiography remains the gold standard but requires hybrid operating room infrastructure rarely available 2
• Combined TTFM with epicardial ultrasonic scanning provides both functional and anatomic assessment 2

Early Postoperative Detection

Routine computed tomography angiography on postoperative day 7 (±4 days) detects silent graft failure before discharge, occurring in 5.2-8.4% of grafts 1, 4:

• Venous graft occlusion rate: 8-11% 1, 4
• Arterial graft occlusion rate: 3-4% 1, 4
• Female patients have significantly higher occlusion rates 4

Continuous ECG monitoring for at least 48 hours postoperatively detects arrhythmias that may indicate ischemia from graft failure 6.

---

Optimization of Graft Function

Conduit Selection Strategy

Use the left internal mammary artery (LIMA) to the LAD and radial artery for the second most important non-LAD vessel to maximize long-term patency 6:

• LIMA to LAD: Class I recommendation with superior long-term outcomes 6
• Radial artery over saphenous vein for second most important stenosed vessel improves cardiac outcomes 6
• Avoid RIMA grafts when possible: 26.8% failure rate at 1 year versus 9.9% for radial artery and 10.4% for saphenous vein 7
• Bilateral internal mammary artery grafting by experienced operators can benefit appropriate patients 6

Intraoperative Technical Optimization

Immediate graft revision when TTFM identifies inadequate flow prevents early failure 2:

• Studies show 9% of grafts have inadequate flow in 25% of patients, leading to revision in 3% of grafts 2
• After anastomotic revision, mean flow increases from 0.5±0.7 to 15.7±9.6 ml/min with resistance decreasing from 138±10 to 4.8±1.8 Ohm 8

Target vessel selection matters:

• Graft to vessels with diameter ≥1.75 mm improves flow 1
• Avoid grafting non-significant stenoses (<70% diameter narrowing): 59% of occluded grafts were performed on non-significant lesions 1

Epiaortic scanning modifies surgical technique in 4-31% of cases, reducing stroke risk by altering cannulation, clamping, and graft attachment sites 2.

Perioperative Medical Optimization

Antiplatelet therapy:

• Initiate aspirin 100-325 mg within 6 hours postoperatively and continue indefinitely to reduce mortality, MI, stroke, and graft failure 6
• Dual antiplatelet therapy with P2Y12 inhibitors shows mixed results; aspirin remains the cornerstone 9

Beta-blocker management:

• Administer beta-blockers for at least 24 hours preoperatively to all patients without contraindications 6
• Reinstitute immediately postoperatively to reduce atrial fibrillation and improve outcomes 6, 10
• Never discontinue perioperatively unless specific contraindications exist 6

Hemodynamic optimization:

• Maintain mean arterial pressure >60 mmHg during cardiopulmonary bypass, particularly in patients with renal dysfunction 10
• Target blood pressure <130/80 mmHg long-term for all post-CABG patients 10

Glycemic control:

• Maintain blood glucose ≤180 mg/dL with continuous IV insulin to reduce deep sternal wound infections 6

ACE inhibitors/ARBs:

• Continue preoperative ACE inhibitors or ARBs through the perioperative period 6

Postoperative Surveillance

Measure biomarkers of myonecrosis (CK-MB, troponin) in the first 24 hours to detect perioperative MI from graft failure 11.

Consider early intervention for detected graft occlusions: 14 patients in one series underwent successful percutaneous revascularization before discharge after CT detection of silent graft failure 4.

---

Critical Pitfalls to Avoid

• Do not rely solely on TTFM positive predictive values (31-80%) as they may lead to unnecessary revisions; negative predictive values are more reliable (91-96%) 3
• Avoid excessive ultrafiltration during bypass (>30 ml/kg) to prevent hypernatremia and intestinal inflammation 6
• Do not use saphenous vein when radial artery is available for non-LAD vessels due to inferior long-term patency 6
• Female patients require heightened vigilance as they demonstrate lower graft flows and higher occlusion rates 1, 4
• Beware of false negatives with TTFM: poor grafts with low PI may not be detected 2